Capsugel Completes Acquisition of Bend Research

Date of Release: 
October 1, 2013


MORRISTOWN, N.J. – October 1, 2013 – Capsugel announced today that it has completed its acquisition of Bend Research Inc., a recognized industry leader in bioavailability enhancement. Bend Research is now part of Capsugel's Dosage Form Solutions (DFS) business. DFS integrates Capsugel’s proprietary technology platforms, formulation R&D centers and finished dosage manufacturing sites to deliver innovative solutions to customers.


Continue Reading


Subscribe to RSS - Other